Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - AVANIR PHARMACEUTICALS, INC. | a54399e10vk.htm |
| EX-23.1 - EX-23.1 - AVANIR PHARMACEUTICALS, INC. | a54399exv23w1.htm |
| EX-32.2 - EX-32.2 - AVANIR PHARMACEUTICALS, INC. | a54399exv32w2.htm |
| EX-31.2 - EX-31.2 - AVANIR PHARMACEUTICALS, INC. | a54399exv31w2.htm |
| EX-31.1 - EX-31.1 - AVANIR PHARMACEUTICALS, INC. | a54399exv31w1.htm |
| EX-21.1 - EX-21.1 - AVANIR PHARMACEUTICALS, INC. | a54399exv21w1.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)
THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)
In connection with the accompanying Annual Report of AVANIR Pharmaceuticals (the “Company”) on Form
10-K for the fiscal year ended September 30, 2009 (the “Report”), I, Keith A Katkin, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
| Dated: November 25, 2009 | /s/ Keith A. Katkin | |||
| Keith A. Katkin | ||||
| President and Chief Executive Officer [Principal Executive Officer] |
||||